Dattilo, G.; Laterra, G.; Licordari, R.; Parisi, F.; Pistelli, L.; Colarusso, L.; Zappia, L.; Vaccaro, V.; Demurtas, E.; Allegra, M.;
et al. The Long-Term Benefit of Sacubitril/Valsartan in Patients with HFrEF: A 5-Year Follow-Up Study in a Real World Population. J. Clin. Med. 2023, 12, 6247.
https://doi.org/10.3390/jcm12196247
AMA Style
Dattilo G, Laterra G, Licordari R, Parisi F, Pistelli L, Colarusso L, Zappia L, Vaccaro V, Demurtas E, Allegra M,
et al. The Long-Term Benefit of Sacubitril/Valsartan in Patients with HFrEF: A 5-Year Follow-Up Study in a Real World Population. Journal of Clinical Medicine. 2023; 12(19):6247.
https://doi.org/10.3390/jcm12196247
Chicago/Turabian Style
Dattilo, Giuseppe, Giulia Laterra, Roberto Licordari, Francesca Parisi, Lorenzo Pistelli, Luigi Colarusso, Luca Zappia, Vittoria Vaccaro, Elisabetta Demurtas, Marta Allegra,
and et al. 2023. "The Long-Term Benefit of Sacubitril/Valsartan in Patients with HFrEF: A 5-Year Follow-Up Study in a Real World Population" Journal of Clinical Medicine 12, no. 19: 6247.
https://doi.org/10.3390/jcm12196247
APA Style
Dattilo, G., Laterra, G., Licordari, R., Parisi, F., Pistelli, L., Colarusso, L., Zappia, L., Vaccaro, V., Demurtas, E., Allegra, M., Crea, P., Di Bella, G., Signorelli, S. S., Aspromonte, N., Imbalzano, E., & Correale, M.
(2023). The Long-Term Benefit of Sacubitril/Valsartan in Patients with HFrEF: A 5-Year Follow-Up Study in a Real World Population. Journal of Clinical Medicine, 12(19), 6247.
https://doi.org/10.3390/jcm12196247
